“…Focal femoral resurfacing of these lesions with mini‐implants has been shown to be a valid alternative. Whilst conventional joint arthroplasty is usually reserved for patients with bone on bone disease, the use of mini‐implants has been mainly advocated as a bridging interim procedure between biological treatments and conventional arthroplasty [4, 6, 10, 28]. In the published literature, these mini‐implants are represented by the HemiCAP ® and UniCAP ® (Anika Therapeutics, Bedford, MA, USA), the Episealer ® (Episealer, Episurf AB, Stockholm, Sweden) and the BioPoly ® (BioPoly, Fort Wayne, IN, USA).…”